Therefore, literature authenticated that andrographolide treatment possesses the potentiality for inhibiting the tumor growth both in vitro and in vivo following different signaling pathways; thus, this study is aimed at foreseeing the effect of andrographolide on iNOS expression in cervical cancer HeLa cells, and the results are in accordance with the previous published reports. The gene discussed is NOS2; the disease is cervical carcinoma.